about
A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionA Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major DepressionAntidepressant Therapy for Bipolar II Major DepressionStudy of the Effects of an Antidepressant Medication and Placebo on the Brain Functioning of Normal SubjectsA Study Of New Medicine (GSK 372475) For The Treatment Of DepressionAripiprazole and Effexor XR Drug Interaction StudyBioavailability Study of Venlafaxine MR Capsules 150 mg Under Fed ConditionsA Relative Bioavailability Study of 50 mg Venlafaxine Hydrochloride Tablets Under Fed ConditionsSerotonin Effect in Functional DyspepsiaStudy Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderStudy of Antidepressants in Parkinson's DiseaseVenlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast CancerKava Kava for the Treatment of Generalized Anxiety Disorder (GAD)A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive DisorderPatient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major DepressionTreatment of Mild to Moderate Depression Symptoms in Patients With Spinal Cord InjuryStudy of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian CountriesThe Treatment of Traumatised Refugees With Sertraline Versus Venlafaxine in Combination With PsychotherapyEffect of Duloxetine and Venlafaxine on the Pharmacokinetics and Pharmacodynamics of Oral Tramadol: A Three-phase Randomized Balanced Cross-over Study in Healthy VolunteersVenlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)Bioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed ConditionsMsFLASH-03: Comparative Efficacy of Low-Dose Estradiol and Venlafaxine XR for Treatment of Menopausal SymptomsEffects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed PatientsEvaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy VolunteersSafety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy VolunteersGabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation TherapyA Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant DepressionFree Venlafaxine Treatment for Marijuana Addiction and Depression - 1A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant DepressionThe Effect of Venlafaxine on Language Function in Patients With Subcortical Aphasia: A fMRI StudyBioequivalence Study of Torrent Pharmaceutical Limited's Venlafaxine Hydrochloride ER Capsules Under Fed Conditions (2011-08-10)Physiologic Monitoring of Antidepressant Treatment Response (2001-06-30)Bioequivalence Study of Venlafaxine Hydrochloride Sustained-Release Capsules in Chinese Healthy Volunteers
P4844
Q61862274-90655C7A-F593-4471-BFFD-386F56D2FCC6Q61914474-75948667-EF5C-4C65-A616-AE4EDAD0822DQ61914776-189FDC0D-7759-49B5-BBA4-5ACAB7D76B67Q61915527-2221206E-ECE6-40E7-9D6A-6B33BB23A424Q61924244-CB92368F-E419-4BDE-B358-3F86EC9D5A4DQ61934884-405FE888-94B9-4201-BFE5-B89C5617E35DQ61955831-1D057B0C-63F8-4C09-9FED-D52CF202FDE7Q61980572-A6D6DFC3-54A2-4DD0-9D44-1A77DABE0C0AQ62104771-D888BFC4-EAE3-46AF-936C-EB1C9E72B00CQ62110365-BE02E965-0EF7-468E-B338-394361644A9FQ62110548-A6EFF6BA-6AB1-429E-A460-C08AA0EA1B34Q62110736-A8A085BF-2168-4B28-B7DC-948B541136E7Q62110838-688A8CD8-ED21-4786-853C-49724495AEA8Q62813001-B94AAFCF-7BF8-4B86-B293-04D98B3B5F87Q63062362-D4C084BB-EF7C-4BF3-B2D0-B788A3338E53Q63063413-FFC9F05C-7A6E-40F6-9FF7-2121251C7A2BQ63316574-E9C059B2-9DF0-4993-9F0D-47214D70B899Q63317154-20ADB72D-BCDE-4A97-8D3B-DC90D8725F35Q63321981-84F9CA6F-ED97-472A-9E48-43628361D640Q63322332-45BBEAED-6ACB-4127-8482-81A27A40BE36Q63322594-2DD6FC68-1196-4B0A-87CD-118BF5BC74D6Q63322697-CA54B835-19F4-4B59-9AE3-AD0A2690874DQ63334173-0FCFCB2E-5B34-40DB-8E87-3D2697F5A1AAQ63334673-35A44D8B-8FDE-412C-96C5-4931DCA4D445Q63335340-19BFAB74-27FD-432B-91EE-52DE0D586A2CQ63340756-71D95B25-9E9E-4126-8DA7-B4245D241313Q63396945-36A5203B-D4AA-4F5B-B13E-B8C5BF20B91FQ63403152-715C26DC-AC76-4144-B2E0-7A9FBDE097C3Q63574113-2AE8C6B8-0DFF-44E1-8B3D-88E72A00657DQ63576364-0B1CF6AD-9A15-49DD-8517-8CDC123A2875Q63600134-8F697D8C-323D-444E-BA7C-3C41AD0243B7Q86170272-A35DBB98-D23E-494C-BE4B-64F6BE04E64BQ86175266-8B5B4945-E22E-4EF1-B136-1344DCA3C207Q87076811-97FEEC45-B173-4BC2-BB3C-CDA9AA472B78
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
venlafaxine hydrochloride
@en
type
label
venlafaxine hydrochloride
@en
altLabel
(+-)-1-(alpha-((Dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol hydrochloride
@en
Venlafaxine HCl
@en
Wy 45030
@en
prefLabel
venlafaxine hydrochloride
@en
P486
P592
P661
P662
P665
P683
P1579
P2067
P2115
N0000148355
P231
99300-78-4
P232
P233
CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl
P234
1S/C17H27NO2.ClH/c1-18(2)13-16 ...... 10,16,19H,4-6,11-13H2,1-3H3;1H
P235
QYRYFNHXARDNFZ-UHFFFAOYSA-N
P2566
100.123.730
P274
C₁₇H₂₈ClNO₂